Dow Up0.08% Nasdaq Down0.30%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NCM
1.46 Up 0.07(5.04%) Sep 19, 4:00PM EDT
|After Hours : 1.46 0.00 (0.00%) Sep 19, 6:07PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJul 31, 2014Apr 30, 2014Jan 31, 2014Oct 31, 2013
Net Income (13,129) (10,248) (9,724) (7,790)
Operating Activities, Cash Flows Provided By or Used In
Depreciation277  249  244  236  
Adjustments To Net Income1,776  1,293  1,605  1,720  
Changes In Accounts Receivables(59)1,450  (846)336  
Changes In Liabilities(1,547)1,466  2,003  (1,395)
Changes In Inventories(468)(306)(1,191)1,646  
Changes In Other Operating Activities507  (413)(226)(239)
Total Cash Flow From Operating Activities (12,643) (6,509) (8,135) (5,486)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(1,349)(212)(490)(26)
Investments -   -   -   -  
Other Cash flows from Investing Activities516  (545)(182)(817)
Total Cash Flows From Investing Activities (833) (757) (672) (843)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid(771)(232) -   -  
Sale Purchase of Stock10,017  21,815  27,545  9,176  
Net Borrowings(4)(4)(4)(4)
Other Cash Flows from Financing Activities -   -   -   -  
Total Cash Flows From Financing Activities 9,242   21,579   27,541   9,172  
Effect Of Exchange Rate Changes -   -   -   -  
Change In Cash and Cash Equivalents (4,234) 14,313   18,734   2,843  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.